All news

(Image: Getty/KatarzynaBialasiewicz)

Roche Alzheimer’s drug suffers trial failure

By Ben Hargreaves

In another blow to discovering a treatment for Alzheimer’s, Roche revealed that preliminary data from two clinical trials meant it was cancelling studies using crenezumab.

Follow us

Products

View more

Webinars